The Aflac Cancer & Blood Disorders Center of Children’s Healthcare of Atlanta has been named a host institution for a collaborative international study sponsored by Novartis. This is a clinical trial analyzing the safety and effectiveness of an investigational cellular therapy treatment for children fighting cancer.

he sickle cell program at the Aflac Cancer & Blood Disorders Center of Children’s Healthcare of Atlanta has been named the lead coordinating center for a National Institute of Health (NIH) study to determine the safety and effectiveness of bone marrow transplants (BMT) compared to standard care therapies to cure sickle cell disease in young adult patients.

After 15 years of dedicated service, William G. Woods, M.D., has stepped down as director of the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta and chief of hematology/oncology/BMT in the Department of Pediatrics at Emory University. He will be succeeded by Douglas Graham, M.D., Ph.D.

Children’s is incorporating Ekso—a wearable robot—or exoskeleton— into its Center for Advanced Technology and Robotic Rehabilitation to continue offering the latest technology to help children and teens recover from injuries or disorders that have hindered their motor skills.

Children’s Healthcare of Atlanta has selected William T. Mahle, M.D. to become the newest Chief of the Children’s Sibley Heart Center.

Children’s Healthcare of Atlanta has selected Ron Frieson to become the next President of the Children’s Healthcare of Atlanta Foundation. Frieson, who currently is serving as the organization’s Chief Public Policy Officer, will succeed Gene Hayes who will retire at the end of 2015.

Home About Children's Latest News test Date: January 01, 0001

Monday, Jan. 01, 0001 About Children’s Healthcare of Atlanta As the only freestanding pediatric healthcare system in Georgia, Children’s Healthcare of Atlanta is the trusted leader in caring for...